整合线上正念与自我关怀训练对成人特应性皮炎疗效的随机临床试验
这项随机临床试验纳入107例DLQI>6的成人特应性皮炎患者,1:1分为线上正念与自我关怀训练组(56例)和等待名单组(51例),两组均允许除度普利尤单抗外的任何皮肤科治疗。第13周时干预组DLQI改善优于等待名单组(组间差值估计-6.34,95%CI -8.27至-4.41,P<.001),所有次要结局也均显示干预组改善更优。作者认为正念与自我关怀训练是成人特应性皮炎的有效治疗选择。
要点
- 第13周DLQI组间差值估计-6.34(95%CI -8.27至-4.41,P<.001),干预组优于等待名单组。
- 标准化效应量Cohen d为-1.06(95%CI -1.39至-0.74)。
- 干预组55例(98.2%)完成8次中至少6次,全部参与者105例(98.1%)完成13周评估。
核心结论
- 在成人特应性皮炎患者中,在常规治疗基础上加用整合线上正念与自我关怀训练,使皮肤病特异性生活质量及包括湿疹严重度在内的其他患者报告结局获得更大改善。
- 作者认为正念与自我关怀训练是成人特应性皮炎的一种有效治疗选择。
研究设计与样本
- 随机临床试验,于2019年3月至2022年10月开展。
- 纳入DLQI评分大于6(对应中度或以上损害)的成人特应性皮炎患者,从日本多家门诊机构及研究社交媒体和网站招募。
- 共随机107例成人,干预组56例,等待名单组51例;参与者总体平均(SD)年龄36.3(10.5)岁,女性85例(79.4%),平均(SD)特应性皮炎病程26.6(11.7)年。
- 干预为每周一次、共8次、每次90分钟的线上正念与自我关怀团体训练,对照组为等待名单;两组均允许接受除度普利尤单抗外的任何皮肤科治疗。
主要发现
- 第13周时干预组DLQI评分改善大于等待名单组,组间差值估计-6.34(95%CI -8.27至-4.41,P<.001)。
- 第13周标准化效应量(Cohen d)为-1.06(95%CI -1.39至-0.74)。
- 所有次要结局均显示干预组较等待名单组改善更优。
- 干预组55例(98.2%)参加了8次中的6次及以上,全部参与者中105例(98.1%)完成了第13周评估。
临床怎么用
- 原文结论指出,这些发现提示正念与自我关怀训练是成人特应性皮炎的一种有效治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Quality of life (QOL) of patients with atopic dermatitis (AD) is reported to be the lowest among skin diseases. To our knowledge, mindfulness and self-compassion training has not been evaluated for adults with AD. OBJECTIVE: To evaluate the efficacy of mindfulness and self-compassion training in improving the QOL for adults with AD. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial conducted from March 2019 through October 2022 included adults with AD whose Dermatology Life Quality Index (DLQI) score, a skin disease-specific QOL measure, was greater than 6 (corresponding to moderate or greater impairment). Participants were recruited from multiple outpatient institutes in Japan and through the study's social media outlets and website. INTERVENTIONS: Participants were randomized 1:1 to receive eight 90-minute weekly group sessions of online mindfulness and self-compassion training or to a waiting list. Both groups were allowed to receive any dermatologic treatment except dupilumab. MAIN OUTCOMES AND MEASURES: The primary outcome was the change in the DLQI score from baseline to week 13. Secondary outcomes included eczema severity, itch- and scratching-related visual analog scales, self-compassion and all of its subscales, mindfulness, psychological symptoms, and participants' adherence to dermatologist-advised treatments. RESULTS: The study randomized 107 adults to the intervention group (n = 56) or the waiting list (n = 51). The overall participant mean (SD) age was 36.3 (10.5) years, 85 (79.4%) were women, and the mean (SD) AD duration was 26.6 (11.7) years. Among participants from the intervention group, 55 (98.2%) attended 6 or more of the 8 sessions, and 105 of all participants (98.1%) completed the assessment at 13 weeks. The intervention group demonstrated greater improvement in the DLQI score at 13 weeks (between-group difference estimate, -6.34; 95% CI, -8.27 to -4.41; P < .001). The standardized effect size (Cohen d) at 13 weeks was -1.06 (95% CI, -1.39 to -0.74). All secondary outcomes showed greater improvements in the intervention group than in the waiting list group. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial of adults with AD, integrated online mindfulness and self-compassion training in addition to usual care resulted in greater improvement in skin disease-specific QOL and other patient-reported outcomes, including eczema severity. These findings suggest that mindfulness and self-compassion training is an effective treatment option for adults with AD. TRIAL REGISTRATION: https://umin.ac.jp/ctr Identifier: UMIN000036277.
引用
- Kishimoto S, Watanabe N, Yamamoto Y, et al. Efficacy of Integrated Online Mindfulness and Self-compassion Training for Adults With Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2023. PMID: 37163257. doi:10.1001/jamadermatol.2023.0975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。